Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a common ADHD drug help veterans with PTSD think clearer and feel better?

NCT ID NCT06573970

Not yet recruiting Symptom relief Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 22 times

Summary

This study tests whether atomoxetine, a non-addictive ADHD medication, can improve attention, thinking skills, and quality of life in 160 veterans with PTSD who also have attention problems. Participants will receive either atomoxetine or a placebo for 12 weeks, and researchers will measure changes in executive function, mood, and daily functioning. The goal is to find a new way to help veterans who don't fully respond to standard PTSD treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTTRAUMATIC STRESS DISORDER WITH ATTENTION DEFIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ralph H. Johnson VA Medical Center, Charleston, SC

    Charleston, South Carolina, 29401-5703, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

POSTTRAUMATIC STRESS DISORDER WITH ATTENTION DEFIC POSTTRAUMATIC STRESS DISORDER WITH ATTENTION DEFIC